Crinetics Pharmaceuticals's total assets for Q1 2025 were $1.36B, a decrease of -5.11% from the previous quarter. CRNX total liabilities were $107.33M for the fiscal quarter, a -2.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.